Patents by Inventor Babak Sayah

Babak Sayah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165275
    Abstract: A composition, containing 10 to 70% of indocyanine green, 0.1 to 15% of ethylenediaminetetraacetic acid (EDTA) and/or one or more salts thereof, 1 to 20% of histidine, and 20 to 80% of sodium chloride. The percentages are expressed by weight relative to a total weight of the indocyanine green, EDTA, histidine, and sodium chloride.
    Type: Application
    Filed: March 14, 2022
    Publication date: May 23, 2024
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Marina LAURENT, Babak SAYAH, Nicolas LOPEZ
  • Publication number: 20240156991
    Abstract: A composition, containing indocyanine green (a), and histidine (b). A weight ratio of histidine (b)/indocyanine green (a) is greater than 0.05. A kit for preparing the composition, containing in separate compartments the indocyanine green (a), and an aqueous solution including the histidine (b). The composition is a medicament or a diagnostic agent.
    Type: Application
    Filed: March 14, 2022
    Publication date: May 16, 2024
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Marina LAURENT, Babak SAYAH, Florian COURIVAUD, Nicolas LOPEZ
  • Patent number: 11891367
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: February 6, 2024
    Assignee: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel Feraud, Babak Sayah, Stéphane Queru, Marina Laurent
  • Publication number: 20230348372
    Abstract: A process for synthesizing a compound of formula (I) including: (a) condensing the benzaldehyde compound of formula (II) with the dialkylaniline of formula (III) to give the triphenylmethane of formula (IV); (b) treating the triphenylmethane of formula (IV) with sulfuric acid to form the triphenylmethane sulfone of the formula (V); and (c) oxidizing the triphenylmethane sulfone of formula (V) with a quinone. Such a process may be used to prepare patent blue.
    Type: Application
    Filed: April 1, 2021
    Publication date: November 2, 2023
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Stephane QUERU, Babak SAYAH, Nicolas DRILLAUD, Nicolas LOPEZ
  • Publication number: 20230159444
    Abstract: A process for preparing a compound of formula including oxidizing the triphenylmethane sulfone of formula (V) with a quinone chosen from 1,4-benzoquinone, 1,2-benzoquinone, a di(C1-C4)alkyl-1,4-benzoquinone, a di(C1-C4)alkyl-1,2-benzoquinone, a mono(C1-C4)alkyl-1,4-benzoquinone and a mono(C1-C4)alkyl-1,2-benzoquinone. A crystalline form of patent blue, sodium salt, can be achieved.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 25, 2023
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Stephane QUERU, Babak SAYAH, Nicolas DRILLAUD, Nicolas LOPEZ
  • Publication number: 20210323937
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel FERAUD, Babak SAYAH, Stéphane QUERU, Marina LAURENT
  • Patent number: 11078169
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Grant
    Filed: February 16, 2018
    Date of Patent: August 3, 2021
    Assignee: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel Feraud, Babak Sayah, Stéphane Queru, Marina Laurent
  • Publication number: 20200283632
    Abstract: Process for preparing disodium 5,5?-indigosulfonate, the feedstock being indigo, this process including the following steps: i) the indigo is subjected to a sulfonation treatment resulting in a mixture that contains 5,5?-indigosulfonic acid, this process including: ii) a reduction treatment is applied to the mixture obtained in step i), and optionally a purification step, so as to obtain a composition including leuco-5,5?-indigosulfonic acid, iii) the leuco-5,5?-indigosulfonic acid is isolated from the composition resulting from step ii), iv) the leuco-5,5?-indigosulfonic acid resulting from step iii) is oxidized to give disodium 5,5?-indigosulfonate.
    Type: Application
    Filed: May 27, 2020
    Publication date: September 10, 2020
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Babak SAYAH, Stéphane QUERU, Michel FERAUD, Nicolas LOPEZ
  • Patent number: 10767054
    Abstract: Process for preparing disodium 5,5?-indigosulfonate, the feedstock being indigo, this process including the following steps: i) the indigo is subjected to a sulfonation treatment resulting in a mixture that contains 5,5?-indigosulfonic acid, this process including: ii) a reduction treatment is applied to the mixture obtained in step i), and optionally a purification step, so as to obtain a composition including leuco-5,5?-indigosulfonic acid, iii) the leuco-5,5?-indigosulfonic acid is isolated from the composition resulting from step ii), iv) the leuco-5,5?-indigosulfonic acid resulting from step iii) is oxidized to give disodium 5,5?-indigosulfonate.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: September 8, 2020
    Assignee: PROVEPHARM LIFE SOLUTIONS
    Inventors: Babak Sayah, Stéphane Queru, Michel Feraud, Nicolas Lopez
  • Publication number: 20200010438
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Application
    Filed: February 16, 2018
    Publication date: January 9, 2020
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel FERAUD, Babak SAYAH, Stéphane QUERU, Marina LAURENT
  • Publication number: 20190292370
    Abstract: Process for preparing disodium 5,5?-indigosulfonate, the feedstock being indigo, this process including the following steps: i) the indigo is subjected to a sulfonation treatment resulting in a mixture that contains 5,5?-indigosulfonic acid, this process including: ii) a reduction treatment is applied to the mixture obtained in step i), and optionally a purification step, so as to obtain a composition including leuco-5,5?-indigosulfonic acid, iii) the leuco-5,5?-indigosulfonic acid is isolated from the composition resulting from step ii), iv) the leuco-5,5?-indigosulfonic acid resulting from step iii) is oxidized to give disodium 5,5?-indigosulfonate.
    Type: Application
    Filed: November 27, 2017
    Publication date: September 26, 2019
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Babak SAYAH, Stéphane QUERU, Michel FERAUD, Nicolas LOPEZ
  • Patent number: 9227945
    Abstract: Process for preparing compounds of the diaminophenothiazinium type of formula (II) below. The products have a high degree of purity and are useful for the preparation of medicaments. In which the R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 groups having the same definition as in formula (I), and R representing a group chosen from: a phenyl or benzyl group, optionally substituted with one or more functions chosen from: a C1-C4 alkyl, a halogen atom, a C1-C4 haloalkyl and a nitro group, a linear, branched or cyclic C1-C8 alkyl group, a C1-C8 alkylamino group, a C1-C8 alkoxy group, a phenyloxy or benzyloxy group optionally substituted on the aromatic nucleus with one or more functions chosen from: a C1-C4 alkyl, a halogen atom, a C1-C4 haloalkyl and a nitro group, Z representing an atom chosen from O and S.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: January 5, 2016
    Assignee: Provence Technologies
    Inventors: Michel Feraud, Babak Sayah
  • Patent number: 8815850
    Abstract: Process for preparing compounds of the diaminophenothiazinium type of formula (II) below. The products have a high degree of purity and are useful for the preparation of medicaments. In which the R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 groups having the same definition as in formula (I), and R representing a group chosen from: a phenyl or benzyl group, optionally substituted with one or more functions chosen from: a C1-C4 alkyl, a halogen atom, a C1-C4 haloalkyl and a nitro group, a linear, branched or cyclic C1-C8 alkyl group, a C1-C8 alkylamino group, a C1-C8 alkoxy group, a phenyloxy or benzyloxy group optionally substituted on the aromatic nucleus with one or more functions chosen from: a C1-C4 alkyl, a halogen atom, a C1-C4 haloalkyl and a nitro group, Z representing an atom chosen from O and S.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: August 26, 2014
    Assignee: Provence Technologies
    Inventors: Michel Feraud, Babak Sayah
  • Publication number: 20140235854
    Abstract: Process for preparing compounds of the diaminophenothiazinium type of formula (II) below. The products have a high degree of purity and are useful for the preparation of medicaments. In which the R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 groups having the same definition as in formula (I), and R representing a group chosen from: a phenyl or benzyl group, optionally substituted with one or more functions chosen from: a C1-C4 alkyl, a halogen atom, a C1-C4 haloalkyl and a nitro group, a linear, branched or cyclic C1-C8 alkyl group, a C1-C8 alkylamino group, a C1-C8 alkoxy group, a phenyloxy or benzyloxy group optionally substituted on the aromatic nucleus with one or more functions chosen from: a C1-C4 alkyl, a halogen atom, a C1-C4 haloalkyl and a nitro group, Z representing an atom chosen from O and S.
    Type: Application
    Filed: April 25, 2014
    Publication date: August 21, 2014
    Applicant: Provence Technologies
    Inventors: Michel Feraud, Babak Sayah
  • Patent number: 8765942
    Abstract: Process for preparing diaminophenothiazinium type compounds having a step for purification of derivatives (II). The diaminophenothiazinium type compounds having the following formula (I): in which R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 may be chosen, independently of the others, from the group constituted of: a hydrogen atom, saturated or unsaturated, linear or branched C1-C6 alkyl groups, or C3-C6 cycloalkyl groups, optionally substituted with one or more functions chosen from a halogen atom, and a C1-C6 alkoxy, C1-C6 alkoxycarbonyl or —CONH2 function, aryl groups optionally substituted with one or more functions chosen from: a C1-C4 alkyl, a halogen atom, and a C1-C6 alkoxy, C1-C6 alkyloxycarbonyl or —CONH2 function, in addition, each of R5, R6, R7, R8, R9 and R10 may be chosen, independently of the others, from the halogen atoms: F, Cl, Br and I, and X? represents an organic or inorganic anion.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: July 1, 2014
    Assignee: Provence Technologies
    Inventors: Michel Feraud, Babak Sayah
  • Publication number: 20130005713
    Abstract: Process for preparing compounds of the diaminophenothiazinium type including a step for purification of derivatives (II). The products resulting from this process have a high degree of purity. Use of these compounds for the preparation of medicaments.
    Type: Application
    Filed: July 19, 2012
    Publication date: January 3, 2013
    Applicant: PROVENCE TECHNOLOGIES
    Inventors: Michel Feraud, Babak Sayah
  • Publication number: 20090291943
    Abstract: Process for preparing compounds of the diaminophenothiazinium type comprising a step for purification of derivatives (II). The products resulting from this process have a high degree of purity. Use of these compounds for the preparation of medicaments.
    Type: Application
    Filed: July 12, 2007
    Publication date: November 26, 2009
    Inventors: Michel Feraud, Babak Sayah